PFKP signaling at a glance: An emerging mediator of cancer cell metabolism

Liwei Lang, Ron Chemmalakuzhy, Chloe Shay, Yong Teng

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Phosphofructokinase-1 (PFK-1), a rate-determining enzyme of glycolysis, is an allosteric enzyme that regulates the oxidation of glucose in cellular respiration. Glycolysis phosphofructokinase platelet (PFKP) is the platelet isoform and works as an important mediator of cell metabolism. Considering that PFKP is a crucial player in many steps of cancer initiation and metastasis, we reviewed the specificities and complexities of PFKP and its biological roles in human diseases, especially malignant tumors. The possible use of PFKP as a diagnostic marker or a drug target in the prevention or treatment of cancer is also discussed.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages243-258
Number of pages16
DOIs
StatePublished - Jan 1 2019

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1134
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Phosphofructokinases
Platelets
Metabolism
Blood Platelets
Cells
Glycolysis
Neoplasms
Phosphofructokinase-1
Cell Respiration
Enzymes
Tumors
Protein Isoforms
Neoplasm Metastasis
Glucose
Oxidation
Pharmaceutical Preparations

Keywords

  • Biologic roles
  • Cancer
  • Diagnostic marker
  • Drug target
  • Gene regulations
  • PFKP

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lang, L., Chemmalakuzhy, R., Shay, C., & Teng, Y. (2019). PFKP signaling at a glance: An emerging mediator of cancer cell metabolism. In Advances in Experimental Medicine and Biology (pp. 243-258). (Advances in Experimental Medicine and Biology; Vol. 1134). Springer New York LLC. https://doi.org/10.1007/978-3-030-12668-1_13

PFKP signaling at a glance : An emerging mediator of cancer cell metabolism. / Lang, Liwei; Chemmalakuzhy, Ron; Shay, Chloe; Teng, Yong.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2019. p. 243-258 (Advances in Experimental Medicine and Biology; Vol. 1134).

Research output: Chapter in Book/Report/Conference proceedingChapter

Lang, L, Chemmalakuzhy, R, Shay, C & Teng, Y 2019, PFKP signaling at a glance: An emerging mediator of cancer cell metabolism. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1134, Springer New York LLC, pp. 243-258. https://doi.org/10.1007/978-3-030-12668-1_13
Lang L, Chemmalakuzhy R, Shay C, Teng Y. PFKP signaling at a glance: An emerging mediator of cancer cell metabolism. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2019. p. 243-258. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-030-12668-1_13
Lang, Liwei ; Chemmalakuzhy, Ron ; Shay, Chloe ; Teng, Yong. / PFKP signaling at a glance : An emerging mediator of cancer cell metabolism. Advances in Experimental Medicine and Biology. Springer New York LLC, 2019. pp. 243-258 (Advances in Experimental Medicine and Biology).
@inbook{98f213ba64e04cc793f9d7012c5caff8,
title = "PFKP signaling at a glance: An emerging mediator of cancer cell metabolism",
abstract = "Phosphofructokinase-1 (PFK-1), a rate-determining enzyme of glycolysis, is an allosteric enzyme that regulates the oxidation of glucose in cellular respiration. Glycolysis phosphofructokinase platelet (PFKP) is the platelet isoform and works as an important mediator of cell metabolism. Considering that PFKP is a crucial player in many steps of cancer initiation and metastasis, we reviewed the specificities and complexities of PFKP and its biological roles in human diseases, especially malignant tumors. The possible use of PFKP as a diagnostic marker or a drug target in the prevention or treatment of cancer is also discussed.",
keywords = "Biologic roles, Cancer, Diagnostic marker, Drug target, Gene regulations, PFKP",
author = "Liwei Lang and Ron Chemmalakuzhy and Chloe Shay and Yong Teng",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-3-030-12668-1_13",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "243--258",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - PFKP signaling at a glance

T2 - An emerging mediator of cancer cell metabolism

AU - Lang, Liwei

AU - Chemmalakuzhy, Ron

AU - Shay, Chloe

AU - Teng, Yong

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Phosphofructokinase-1 (PFK-1), a rate-determining enzyme of glycolysis, is an allosteric enzyme that regulates the oxidation of glucose in cellular respiration. Glycolysis phosphofructokinase platelet (PFKP) is the platelet isoform and works as an important mediator of cell metabolism. Considering that PFKP is a crucial player in many steps of cancer initiation and metastasis, we reviewed the specificities and complexities of PFKP and its biological roles in human diseases, especially malignant tumors. The possible use of PFKP as a diagnostic marker or a drug target in the prevention or treatment of cancer is also discussed.

AB - Phosphofructokinase-1 (PFK-1), a rate-determining enzyme of glycolysis, is an allosteric enzyme that regulates the oxidation of glucose in cellular respiration. Glycolysis phosphofructokinase platelet (PFKP) is the platelet isoform and works as an important mediator of cell metabolism. Considering that PFKP is a crucial player in many steps of cancer initiation and metastasis, we reviewed the specificities and complexities of PFKP and its biological roles in human diseases, especially malignant tumors. The possible use of PFKP as a diagnostic marker or a drug target in the prevention or treatment of cancer is also discussed.

KW - Biologic roles

KW - Cancer

KW - Diagnostic marker

KW - Drug target

KW - Gene regulations

KW - PFKP

UR - http://www.scopus.com/inward/record.url?scp=85063966138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063966138&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-12668-1_13

DO - 10.1007/978-3-030-12668-1_13

M3 - Chapter

C2 - 30919341

AN - SCOPUS:85063966138

T3 - Advances in Experimental Medicine and Biology

SP - 243

EP - 258

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -